SAM
RARE icon

Smartleaf Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History

Smartleaf Asset Management’s Portfolio RARE Stock Details RARE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$176K Hold
5,723
– – 0.01% 889
2026
Q1 		$110K Buy
5,723
+3,234
+130% +$72.8K ﹤0.01% 1059
2025
Q4 		$56.7K Buy
2,489
+751
+43% +$24.7K ﹤0.01% 1484
2025
Q3 		$52.8K Buy
1,738
+1,169
+205% +$35.1K ﹤0.01% 1375
2025
Q2 		$20.8K Sell
569
-158
-22% -$5.7K ﹤0.01% 1537
2025
Q1 		$27.5K Buy
727
+44
+6% +$1.83K ﹤0.01% 1446
2024
Q4 		$28.9K Buy
683
+493
+259% +$24.5K ﹤0.01% 1452
2024
Q3 		$10.3K Buy
190
+74
+64% +$3.77K ﹤0.01% 1738
2024
Q2 		$4.8K Buy
116
+106
+1,060% +$4.53K ﹤0.01% 1828
2024
Q1 		$468 Buy
+10
New +$472 ﹤0.01% 1751

Other funds holding RARE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $26.9B AUM 34.44% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $10.7B AUM 67.78% 1-Year Est. Return

Smartleaf Asset Management's RARE Position: Q2 2026 in Review

Smartleaf Asset Management held its Ultragenyx Pharmaceutical (RARE) position steady in Q2 2026 at 5,723 shares worth $176K. The position accounts for 0.01% of the portfolio, ranked #889.

Smartleaf Asset Management first reported a position in RARE in Q1 2024 and has held it in 10 quarters since. 311 funds tracked by Wall St. Rank hold RARE as of Q2 2026.

  • Smartleaf Asset Management held 5,723 shares of Ultragenyx Pharmaceutical worth $176K as of Q2 2026.
  • Smartleaf Asset Management left its Ultragenyx Pharmaceutical share count unchanged in Q2 2026.
  • Ultragenyx Pharmaceutical made up 0.01% of Smartleaf Asset Management's portfolio in Q2 2026, its #889 holding.
  • Smartleaf Asset Management first reported a position in Ultragenyx Pharmaceutical in Q1 2024 and has held it in 10 quarters since.
  • 311 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q2 2026.

Based on Smartleaf Asset Management's 13F filing for Q2 2026, filed 12 Aug 2026.